Fetzima
My Prescription
Payment
Select pharmacy
$544.89
Print or send this coupon to your phone
AlbertsonsPowered byAbout Fetzima
Drug Details
Levomilnacipran, marketed under the brand name Fetzima, is prescribed for the treatment of depression. As a serotonin-norepinephrine reuptake inhibitor (SNRI), it functions by enhancing the balance of serotonin and norepinephrine in the brain, which are crucial for mood regulation. While it may take several weeks to experience the full therapeutic effects, this medication plays a vital role in improving mood stability. It is important to discuss with your healthcare provider before starting this medication to ensure it is appropriate for your needs.
Price history for Fetzima
30 Capsule Extended Release 24 Hours, 20MG
Average retail price for Fetzima
Average SaveHealth price for Fetzima
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Fetzima dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 20MG | 30 Capsule Extended Release 24 Hours | $545.09 | $18.17 |
| 40MG | 30 Capsule Extended Release 24 Hours | $545.13 | $18.17 |
| 80MG | 30 Capsule Extended Release 24 Hours | $544.62 | $18.15 |
| 120MG | 30 Capsule Extended Release 24 Hours | $544.63 | $18.15 |
Fetzima FAQs
Fetzima is used for the treatment of major depressive disorder (MDD) in adults.
Fetzima (levomilnacipran) is an antidepressant that may cause weight changes in some individuals. While weight loss is not a common side effect, it has been reported in some cases. However, weight gain is also possible. It's important for individuals to monitor any changes in weight and discuss them with their healthcare provider.
A drug that is comparable to Fetzima (levomilnacipran) is Cymbalta (duloxetine). Both are serotonin-norepinephrine reuptake inhibitors (SNRIs) used to treat major depressive disorder. However, it is important for patients to consult with their healthcare provider to determine the most appropriate medication for their specific condition.
Fetzima (levomilnacipran) is primarily approved for the treatment of major depressive disorder (MDD). While it is not specifically approved for the treatment of anxiety disorders, some patients with depression and co-occurring anxiety symptoms may experience an improvement in anxiety as their depression is treated. However, it is important for patients to consult with their healthcare provider to determine the most appropriate treatment for their specific condition.
Fetzima (levomilnacipran) should not be taken with certain medications due to potential interactions. These include:1. Monoamine oxidase inhibitors (MAOIs) - such as phenelzine or tranylcypromine.2. Other serotonergic drugs - like SSRIs, SNRIs, triptans, or tramadol, which can increase the risk of serotonin syndrome.3. Blood thinners - such as warfarin, as it may increase bleeding risk.4. Nonsteroidal anti-inflammatory drugs (NSAIDs) - like ibuprofen or aspirin, which can also increase bleeding risk.5. Alcohol - as it can exacerbate side effects like dizziness or drowsiness.It is important to consult a healthcare provider before starting or stopping any medications while taking Fetzima.